miR‐182 binds with tumor suppressor genes like ANGPTL1, MTSS1, RASA1, PDCD4, EphrinA5, SOX11, and Cebpa and suppresses their expression, which leads to HCC development, as represented in Figure 6B (Table S1). The gene discussed is CEBPA; the disease is hepatocellular carcinoma.